Study shows no mitotane needed for patients with low risk of recurrence of adrenocortical carcinoma

In 2007, the teams of Massimo Terzolo and Martin Fassnacht published a study in the New England Journal of Medicine that provided evidence for the efficacy of mitotane in the prevention of recurrence in adrenocortical carcinoma. This study established the drug worldwide as a standard therapy for relapse prophylaxis after surgical removal of the tumor, regardless of risk factors that were still unknown at the time.

Unraveling the mechanism behind obesity-induced pancreatic β-cell dysfunction

Obesity not only increases the risk of metabolic syndrome-related diseases, such as diabetes, fatty liver, and atherosclerosis, but also remarkably impacts seemingly unrelated conditions, such as cancer, psychiatric disorders, and immune function. To understand this wide range of diseases and develop therapeutic approaches for the same, it is important to elucidate the mechanisms by which various organ and cell functions are impaired in the pathogenesis of obesity.

Northern Province has scored huge developments – PS 

NORTHERN Province Permanent Secretary Bernard Mpundu has said the province has received massive developments in the past two years that the United Party for National Development UPND has been in office.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.


Mr Mpundu has pointed out the increase in the Constituency Development Fund (CDF) from K 1.6 million to K25.7 million and now increased it to K28.3 million kwacha.

Mr Mpundu said the significant increase has seen realistic development taking place in the province.

He cited the construction of classroom blocks and health posts dotted across the province as some of the developments.

He further explained that the CDF has further impacted positively on the communities through the rehabilitation and construction of collapsed bridges on various crossing points.

And Mr Mpundu said the partial withdrawal of benefits under NAPSA is another major achievement that has been actualized by the government.

He said many people have attested to the fact that they have been able to access the funds which can be used while they are still energetic.

“I have met a young man who is building a house using the money he withdrew from NAPSA, he told me the money will not complete his house but that starting the project is very important for him,” Mr Mpundu explained.

And Northern Province Social Welfare Officer Sebastian Pasuwa said the department had a total of 69 711 caseload of households on the social cash transfer from 2021 which has been increased to more than 120,000 beneficiaries.

Mr Pasuwa explained that in the past two years, the social cash transfer was increased from K300 to K400 for households without a person with a disability.

He added that the funds for households with a member with a disability rose to eight hundred kwacha from six hundred kwacha.

Mr Pasuwa said the social cash transfer is impacting positively on the vulnerable households in the province.

“The social cash transfer programme is helping in reducing generational poverty among the households,” he explained.

“We have seen some households building better housing units from grass thatched and others have bought livestock,” he added. – ZANIS.

[/ihc-hide-content

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

Researchers at The University of Texas MD Anderson Cancer Center have uncovered a functional role for KRAS mutations in pancreatic cancer and rapidly translated these findings into a novel therapeutic approach combining a KRAS G12D inhibitor with immune checkpoint inhibitors for early- and late-stage KRAS G12D-mutant pancreatic cancer. The combination therapy led to durable tumor elimination and significantly improved survival outcomes in preclinical models, leading to the launch of a Phase I clinical trial.

ChatGPT shows limited ability to recommend guidelines-based cancer treatments

For many patients, the internet serves as a powerful tool for self-education on medical topics. With ChatGPT now at patients’ fingertips, researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham health care system, assessed how consistently the artificial intelligence chatbot provides recommendations for cancer treatment that align with National Comprehensive Cancer Network (NCCN) guidelines.